127 related articles for article (PubMed ID: 7986200)
1. Role of the CYP2D subfamily in metabolism-dependent covalent binding of propranolol to liver microsomal protein in rats.
Masubuchi Y; Narimatsu S; Hosokawa S; Suzuki T
Biochem Pharmacol; 1994 Nov; 48(10):1891-8. PubMed ID: 7986200
[TBL] [Abstract][Full Text] [Related]
2. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
3. Participation of the CYP2D subfamily in lidocaine 3-hydroxylation and formation of a reactive metabolite covalently bound to liver microsomal protein in rats.
Masubuchi Y; Umeda S; Igarashi S; Fujita S; Narimatsu S; Suzuki T
Biochem Pharmacol; 1993 Nov; 46(10):1867-9. PubMed ID: 8250975
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein.
Masubuchi Y; Araki J; Narimatsu S; Suzuki T
Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol.
Narimatsu S; Arai T; Masubuchi Y; Horie T; Hosokawa M; Ueno K; Kataoka H; Yamamoto S; Ishikawa T; Cho AK
Biol Pharm Bull; 2001 Sep; 24(9):988-94. PubMed ID: 11558582
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
8. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK
Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of rat hepatic microsomal propranolol metabolism by a covalently bound reactive metabolite.
Pritchard JF; Schneck DW; Hayes AH
Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):211-22. PubMed ID: 6768117
[TBL] [Abstract][Full Text] [Related]
10. Activation of propranolol and irreversible binding to rat liver microsomes: strain differences and effects of inhibitors.
Masubuchi Y; Narimatsu S; Suzuki T
Biochem Pharmacol; 1992 Feb; 43(3):635-7. PubMed ID: 1540217
[TBL] [Abstract][Full Text] [Related]
11. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T
Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).
He K; Woolf TF; Hollenberg PF
J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of propranolol-induced impairment of its own metabolism in rats.
Kagimoto N; Masubuchi Y; Fujita S; Narimatsu S; Suzuki T
J Pharm Pharmacol; 1994 Jun; 46(6):528-30. PubMed ID: 7932057
[TBL] [Abstract][Full Text] [Related]
14. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 isozymes involved in aromatic hydroxylation and side-chain N-desisopropylation of alprenolol in rat liver microsomes.
Narimatsu S; Tachibana M; Masubuchi Y; Imaoka S; Funae Y; Suzuki T
Biol Pharm Bull; 1995 Aug; 18(8):1060-5. PubMed ID: 8535396
[TBL] [Abstract][Full Text] [Related]
16. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical characterization of a cytochrome P450 isozyme and a protein purified from liver microsomes of male guinea pigs and their roles in the oxidative metabolism of delta 9-tetrahydrocannabinol by guinea pig liver microsomes.
Narimatsu S; Akutsu Y; Matsunaga T; Watanabe K; Yamamoto I; Yoshimura H
Biochem Pharmacol; 1992 Apr; 43(8):1729-36. PubMed ID: 1315542
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
[TBL] [Abstract][Full Text] [Related]
20. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
